ロード中...
Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
BACKGROUND: It is uncertain whether pharmacological reductions in very‐low‐density lipoproteins (VLDLs), and their component triglyceride and cholesterol could reduce residual risk of atherosclerotic cardiovascular disease (ASCVD) events among individuals in whom low‐density lipoprotein cholesterol...
保存先:
| 出版年: | J Am Heart Assoc |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5779048/ https://ncbi.nlm.nih.gov/pubmed/29223956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007402 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|